RACK1 and cancer: In patients with androgen-independent PCa, TRPM7 enhances hypoxia-induced malignant migration and invasion of cancer cells by impeding the degradation of HIF-1α mediated by the receptor for Activated C Kinase 1 (RACK1) [138].